Progression of Chronic Kidney Disease: Adrenergic Genetic Influence on Glomerular Filtration Rate Decline in Hypertensive Nephrosclerosis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Nephrology

• Publication date

  2010-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000313927PMID 20484896PMCID PMC2914391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autonomic Function in Hypertension: Role of Genetic Variation at the Catecholamine Storage Vesicle Protein Chromogranin B

  2009cited by this paper
• Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

  2009cited by this paper
• Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

  2009cited by this paper
• Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

  2009cited by this paper
• Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis.

  2009cited by this paper
• Chromogranin A polymorphisms are associated with hypertensive renal disease.

  2008cited by this paper
• Renal Albumin Excretion: Twin Studies Identify Influences of Heredity, Environment, and Adrenergic Pathway Polymorphism

  2007cited by this paper
• Renal Effects of β2-Adrenoceptor Agonist and the Clinical Analysis in Children

  2007cited by this paper
• Generalized Analysis of Molecular Variance

  2007cited by this paper
• Pyrosequencing: history, biochemistry and future.

  2006cited by this paper
• The beta2-adrenoceptor gene and hypertension: is it the promoter or the coding region or neither?

  2006cited by this paper
• β2- and β3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years

  2005cited by this paper
• Interactive Effects of Common &bgr;2-Adrenoceptor Haplotypes and Age on Susceptibility to Hypertension and Receptor Function

  2005cited by this paper
• Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.

  2005cited by this paper
• Haplotype reconstruction from genotype data using Imperfect Phylogeny

  2004influential reference
• Functional responses of human beta1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms.

  2004cited by this paper
• Haplotypes of the β2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population

  2004cited by this paper
• Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins.

  2004cited by this paper
• Association of the tissue kallikrein gene promoter with ESRD and hypertension.

  2002cited by this paper
• β2 adrenergic receptor 5′ haplotypes influence promoter activity

  2002cited by this paper
• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.

  2002cited by this paper
• High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2001cited by this paper
• Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

  2001cited by this paper
• Early Alteration in Glomerular Reserve in Humans at Genetic Risk of Essential Hypertension: Mechanisms and Consequences

  2001cited by this paper
• Immunofluorescent imaging of beta 1- and beta 2-adrenergic receptors in rat kidney.

  2001cited by this paper
• The glycine allele of a glycine/arginine polymorphism in the beta2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin.

  2001cited by this paper
• Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African‐American populations

  2000cited by this paper
• Genetic analysis of nitric oxide and endothelin in end-stage renal disease.

  2000cited by this paper
• Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.

  2000cited by this paper
• Genetic susceptibility to end-stage renal disease.

  1999cited by this paper
• A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

  1999cited by this paper
• Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension.

  1998cited by this paper
• Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.

  1997cited by this paper
• Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.

  1997cited by this paper
• Role of renal nerves and endogenous dopamine in amino acid-induced glomerular hyperfiltration.

  1997cited by this paper
• Pathophysiology and treatment implications of hypertension in the African-American population.

  1997cited by this paper
• Cold‐induced stress stimulates the sympathetic nervous system, causing hypertension and proteinuria in rats

  1997cited by this paper
• Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

  1996cited by this paper
• Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.

  1996cited by this paper
• Renal afferent denervation prevents hypertension in rats with chronic renal failure.

  1995cited by this paper
• Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure.

  1994cited by this paper
• Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

  1994cited by this paper
• Normotensive blacks have heightened sympathetic response to cold pressor test.

  1993cited by this paper
• The familial risk of end-stage renal disease in African Americans.

  1993cited by this paper
• Sympathetic overactivity in patients with chronic renal failure.

  1992cited by this paper
• Autonomic function in hypertension. Are there racial differences?

  1990cited by this paper
• Race, borderline hypertension, and hemodynamic responses to behavioral stress before and after beta-adrenergic blockade.

  1989cited by this paper
• A familial risk of chronic renal failure among blacks on dialysis?

  1988cited by this paper
• Intraglomerular hypertension: implications and drug treatment.

  1988cited by this paper
• Effects of race and marginally elevated blood pressure on responses to stress.

  1987cited by this paper
• Effect of renal nerve stimulation on NaCl and H2O transport in Henle's loop of the rat.

  1982cited by this paper
• Production of renal ischemia and proteinuria in man by the adrenal medullary hormones.

  1956cited by this paper

• A subgrid model with multiple relaxation time for lattice Boltzmann method based on the Cartesian grid

  2023cites this paper
• β2-Adrenergic Receptor Agonism as a therapeutic strategy for kidney disease.

  2021cites this paper
• Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy

  2018cites this paper
• Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats.

  2015cites this paper
• Genome-wide association study of kidney function decline in individuals of European descent

  2014cites this paper
• Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors

  2014cites this paper
• Potassium Concentration on Admission Is an Independent Risk Factor for Target Lesion Revascularization in Acute Myocardial Infarction

  2014cites this paper
• Heritable Influence of DBH on Adrenergic and Renal Function: Twin and Disease Studies

  2013cites this paper
• Renal-protective effect of nicousamide on hypertensive nephropathy in spontaneously hypertensive rats.

  2013cites this paper
• Sympathetic regulation of vascular function in health and disease

  2012cites this paper
• Heart rate, age and the risk of progression to kidney failure in patients with CKD.

  2012cites this paper
• Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans

  2012cites this paper
• Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

  2011cites this paper
• Relationship between Stage of Kidney Disease and Incident Heart Failure in Older Adults

  2011cites this paper